These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12169646)

  • 1. Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy.
    Bishop-Bailey D; Hla T; Warner TD
    Circ Res; 2002 Aug; 91(3):210-7. PubMed ID: 12169646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist.
    Bishop-Bailey D; Warner TD
    FASEB J; 2003 Oct; 17(13):1925-7. PubMed ID: 12897060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
    Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
    Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells.
    Ikeda U; Shimpo M; Murakami Y; Shimada K
    Hypertension; 2000 Jun; 35(6):1232-6. PubMed ID: 10856269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells.
    Iijima K; Yoshizumi M; Ako J; Eto M; Kim S; Hashimoto M; Sugimoto N; Liang YQ; Sudoh N; Toba K; Ouchi Y
    Biochem Biophys Res Commun; 1998 Jun; 247(2):353-6. PubMed ID: 9642130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
    Pang L; Nie M; Corbett L; Knox AJ
    J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
    Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
    Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors and hepatic stellate cell activation.
    Miyahara T; Schrum L; Rippe R; Xiong S; Yee HF; Motomura K; Anania FA; Willson TM; Tsukamoto H
    J Biol Chem; 2000 Nov; 275(46):35715-22. PubMed ID: 10969082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
    Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein.
    Pontsler AV; St Hilaire A; Marathe GK; Zimmerman GA; McIntyre TM
    J Biol Chem; 2002 Apr; 277(15):13029-36. PubMed ID: 11809750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abietic acid activates peroxisome proliferator-activated receptor-gamma (PPARgamma) in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism.
    Takahashi N; Kawada T; Goto T; Kim CS; Taimatsu A; Egawa K; Yamamoto T; Jisaka M; Nishimura K; Yokota K; Yu R; Fushiki T
    FEBS Lett; 2003 Aug; 550(1-3):190-4. PubMed ID: 12935909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
    Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of PPARgamma in rat and human vascular smooth muscle cells.
    Law RE; Goetze S; Xi XP; Jackson S; Kawano Y; Demer L; Fishbein MC; Meehan WP; Hsueh WA
    Circulation; 2000 Mar; 101(11):1311-8. PubMed ID: 10725292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
    Staels B; Koenig W; Habib A; Merval R; Lebret M; Torra IP; Delerive P; Fadel A; Chinetti G; Fruchart JC; Najib J; Maclouf J; Tedgui A
    Nature; 1998 Jun; 393(6687):790-3. PubMed ID: 9655393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect.
    Armoni M; Kritz N; Harel C; Bar-Yoseph F; Chen H; Quon MJ; Karnieli E
    J Biol Chem; 2003 Aug; 278(33):30614-23. PubMed ID: 12777391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha.
    Malerød L; Sporstøl M; Juvet LK; Mousavi A; Gjøen T; Berg T
    Biochem Biophys Res Commun; 2003 Jun; 305(3):557-65. PubMed ID: 12763030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists.
    Davies SS; Pontsler AV; Marathe GK; Harrison KA; Murphy RC; Hinshaw JC; Prestwich GD; Hilaire AS; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 2001 May; 276(19):16015-23. PubMed ID: 11279149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.